varieti
flavonoid
structur
identifi
compound
compris
flavan
nucleu
fifteencarbon
skeleton
consist
two
benzen
ring
bring
shown
fig
connect
via
heterocycl
pyren
ring
cring
shown
fig
flavonoid
divid
sever
class
anthocyanidin
flavon
flavonol
flavanon
flavan
isoflavanoid
biflavanoid
etc
tabl
variou
class
flavonoid
differ
level
oxid
pattern
substitut
pyren
ring
wherea
individu
compound
within
class
differ
pattern
substitut
benzen
ring
flavonoid
bring
link
cring
posit
bring
isoflavonoid
substitut
posit
fig
biflavonoid
compris
two
ident
nonident
flavonoid
unit
conjoin
alkyl
alkoxybas
linker
fig
plant
flavonoid
gener
occur
aglycon
glycosid
methyl
deriv
biosynthes
phenylpropanoid
pathway
transform
phenylalanin
enter
flavonoid
biosynthesi
pathway
depend
plant
speci
group
enzym
hydroxylas
reductas
modifi
basic
flavonoid
skeleton
result
differ
flavonoid
class
final
transferas
modifi
flavonoid
skeleton
sugar
methyl
group
acyl
moieti
modif
alter
solubl
reactiv
flavonoid
larg
bodi
evid
support
role
light
regul
flavonoid
biosynthesi
flavon
constitut
major
class
flavonoid
famili
base
backbon
natur
flavon
includ
apigenin
baicalein
chrysin
luteolin
scutellarein
tangeritin
wogonin
antivir
activ
flavon
known
show
simultan
applic
apigenin
acyclovir
result
enhanc
antivir
effect
herp
simplex
viru
type
cell
cultur
apigenin
commonli
isol
abund
famili
asteracea
organ
aqueou
extract
asteracea
plant
apigenin
major
compound
found
activ
polioviru
type
hepat
c
viru
hcv
apigenin
isol
sweet
basil
ocimum
basilicum
show
potent
antivir
activ
adenovirus
adv
hepat
b
viru
vitro
besid
dna
virus
apigenin
found
exert
antivir
effect
african
swine
fever
viru
asfv
suppress
viral
protein
synthesi
reduc
asfv
yield
log
apigenin
also
activ
rna
virus
picronavirus
shown
apigenin
abl
inhibit
viral
protein
synthesi
suppress
viral
ire
activ
furthermor
apigenin
affect
translat
disrupt
viral
rna
associ
transact
factor
regul
translat
shibata
et
al
show
apigenin
antivir
effect
hcv
reduct
matur
liverspecif
microrna
posit
regul
hcv
replic
among
flavon
baicalein
luteolin
also
extens
investig
respect
antivir
activ
baicalein
significantli
reduc
level
human
cytomegaloviru
hcmv
earli
late
protein
well
viral
dna
synthesi
although
effect
viral
polymeras
activ
baicalein
impair
avian
influenza
viru
replic
human
lung
epitheli
cell
monocytederiv
macrophag
interf
neuraminidas
activ
studi
show
oral
administr
baicalein
balbc
mice
infect
influenza
viru
decreas
lung
viru
titer
increas
mean
time
death
similar
effect
record
mice
infect
sendai
viru
inhibitori
effect
vivo
mediat
serum
baicalin
metabolit
baicalein
glucos
residu
baicalin
alon
exert
antiinfluenza
activ
modul
function
protein
downregul
ifn
induct
studi
indic
baicalin
directli
induc
product
human
cell
cell
act
potent
induc
influenza
viru
infect
recent
novel
baicalein
analog
bring
substitut
bromin
atom
demonstr
extrem
potent
activ
influenza
tamifluresist
viru
indic
baicalein
analog
favor
altern
manag
tamifluresist
virus
vitro
replic
suppress
baicalin
infect
cell
treat
earli
stage
viru
replic
cycl
envelop
protein
found
target
site
baicalin
antivir
action
via
interfer
interact
viru
structur
protein
specif
host
immun
cell
baicalein
baicalin
also
investig
dengu
viru
denv
exert
signific
virucid
effect
extracellular
viral
particl
interf
differ
step
replic
silico
studi
reveal
baicalein
strong
bind
affin
denv
protein
kcalmol
baicalin
may
interact
close
viru
protein
bind
affin
kcalmol
baicalin
comput
studi
also
show
high
bind
affin
kcalmol
chikungunya
viru
chikv
protein
suggest
baicalin
potenti
interfer
chikv
infect
found
luteolin
antivir
effect
reactiv
block
clade
b
ctatdriven
ltr
transactiv
luteolin
also
show
signific
inhibit
epsteinbarr
viru
ebv
reactiv
cell
suppress
activ
immediateearli
gene
zta
rta
deregul
transcript
factor
bind
xu
et
al
test
highli
purifi
natur
compound
inhibit
coxsackieviru
infect
found
luteolin
exhibit
potent
inhibit
disrupt
viral
rna
replic
besid
antivir
activ
luteolin
luteolinrich
fraction
show
antivir
effect
sever
acut
respiratori
syndrom
coronaviru
sarscov
rhesu
rotaviru
chikv
japanes
enceph
viru
jev
flavonol
character
backbon
among
flavonol
antivir
effect
quercetin
extens
investig
earli
vivo
studi
show
oral
treatment
quercetin
protect
mice
lethal
mengo
viru
furthermor
enhanc
protect
observ
quercetin
administ
combin
murin
type
interferon
ifn
quercetin
also
demonstr
dosedepend
antivir
activ
polioviru
type
respiratori
syncyti
viru
rsv
cell
cultur
epimedium
koreanum
nakai
contain
quercetin
major
activ
compon
shown
induc
secret
type
ifn
reduc
replic
hsv
newcastl
diseas
viru
ndv
vesicular
stomat
viru
vsv
vitro
well
influenza
subtyp
vivo
hung
et
al
suggest
possibl
mechan
wherebi
quercetin
may
exert
antihsv
activ
reveal
quercetin
inhibit
infect
acyclovirresist
mainli
block
viral
bind
penetr
host
cell
also
report
quercetin
suppress
activ
essenti
hsv
gene
express
recent
investig
also
point
antivir
activ
quercetin
wide
spectrum
influenza
viru
strain
interact
influenza
hemagglutinin
protein
therebi
inhibit
viralcel
fusion
addit
silico
analysi
reveal
quercetin
may
potenti
inhibitor
neuraminidas
influenza
virus
molecular
dock
analysi
also
found
quercetin
may
interact
hcv
helicas
polymeras
protein
result
correl
experiment
studi
show
antihcv
activ
quercetin
inhibit
helicas
heat
shock
protein
besid
virus
inhibitori
activ
quercetin
deriv
report
virus
includ
adv
arthropodborn
mayaro
viru
porcin
reproduct
respiratori
syndrom
viru
canin
distemp
viru
jev
porcin
epidem
diarrhea
viru
equid
herpesviru
quercetin
also
possess
antirhinovir
effect
inhibit
endocytosi
transcript
viral
genom
viral
protein
synthesi
mice
infect
rhinoviru
quercetin
treatment
decreas
viral
replic
attenu
virusinduc
airway
cholinerg
hyperrespons
kaempferol
anoth
flavonol
extract
differ
medicin
herb
kaempferol
deriv
bear
acyl
substitu
shown
inhibitori
activ
hcmv
kaempferol
deriv
isol
ficu
benjamina
leav
effect
aglycon
form
kaempferol
deriv
rhamnos
residu
turn
potent
inhibitor
channel
coronaviru
involv
mechan
viru
releas
one
kaempferol
deriv
kaempferol
obtain
zanthoxylum
piperitum
shown
significantli
inhibit
replic
influenza
viru
vitro
behbahani
et
al
found
kaempferol
strong
revers
transcriptas
inhibitori
activ
compound
exert
effect
concentr
earli
stage
hiv
replic
target
cell
recent
isol
chines
medicin
taxillu
sutchuenensi
shown
potent
vitro
activ
hcv
proteas
function
antivir
activ
kaempferol
influenza
virus
mention
studi
conduct
group
research
south
korea
mechanist
structur
studi
suggest
compound
act
viru
neuraminidas
protein
specif
function
group
respons
kaempferol
efficaci
studi
compar
antivir
activ
kaempferol
isoflavon
daidzein
show
kaempferol
exert
potent
inhibitori
activ
jev
replic
protein
express
daidzein
jev
frameshift
site
rna
fsrna
propos
target
site
kaempferol
inhibitori
activ
flaviviru
seo
et
al
conduct
studi
compar
potenc
differ
class
flavonoid
two
rna
virus
name
murin
noroviru
felin
caliciviru
find
demonstr
among
flavonoid
test
kaempferol
exhibit
potent
inhibitori
activ
two
virus
number
flavonol
deriv
act
antivir
exampl
sulfat
rutin
modifi
glycosid
rutin
demonstr
signific
activ
differ
isol
compound
inhibit
infect
block
viral
entri
viruscel
fusion
like
interact
envelop
glycoprotein
rutin
concentr
shown
inhibit
infect
suppress
activ
signal
pathway
requir
replic
rutin
fisetin
also
inhibit
replic
affect
enzymat
activ
proteas
fisetin
treatment
caus
dosedepend
decreas
product
chikv
nonstructur
protein
inhibit
viral
infect
moreov
zandi
et
al
show
rna
copi
number
significantli
reduc
follow
addit
fisetin
infect
cell
yu
et
al
found
myricetin
may
serv
chemic
inhibitor
sarscoronaviru
affect
atpas
activ
viral
helicas
flavan
character
skeleton
compound
includ
among
antivir
activ
catechin
deriv
epicatechin
epicatechin
gallat
epigallocatechin
egc
epigallocatechin
gallat
egcg
found
tea
larg
investig
among
differ
virus
studi
potenti
target
influenza
viru
receiv
attent
initi
report
nakayama
et
al
show
tea
catechin
particularli
egcg
abl
bind
haemagglutinin
influenza
viru
prevent
adsorpt
madindarbi
canin
kidney
cell
furthermor
suggest
egcg
may
abl
damag
physic
properti
viral
envelop
result
inhibit
hemifus
event
influenza
viru
cellular
membran
recent
colpitt
schang
report
egcg
compet
sialic
acid
bind
influenza
viru
therebi
block
primari
lowaffin
attach
cell
anoth
tea
catechin
egc
exert
inhibitori
effect
acidif
endosom
lysosom
therebi
reduc
viral
entri
via
clathrinmedi
endocytosi
structurefunct
relationship
analysi
tea
catechin
reveal
import
role
group
catechin
skeleton
antivir
activ
result
also
show
modif
posit
significantli
affect
antivir
activ
catechin
deriv
contain
carbon
chain
posit
demonstr
potent
antiinfluenza
activ
vitro
ovo
sever
report
demonstr
tea
catechin
antivir
effect
hiv
infect
among
tea
catechin
egcg
effect
exert
antivir
effect
throughout
sever
step
life
cycl
directli
bind
molecul
consequ
inhibit
bind
envelop
protein
studi
identifi
potenti
site
interact
galloyl
moieti
egcg
residu
involv
interact
viral
furthermor
earli
studi
nakan
ono
show
egcg
ecg
effect
inhibit
revers
transcriptas
vitro
tillekeratn
et
al
modifi
molecular
structur
egcg
determin
minimum
structur
characterist
necessari
revers
transcriptas
inhibit
studi
gallat
ester
moieti
found
import
inhibit
besid
effect
egcg
abil
reduc
viral
product
chronic
infect
monocytoid
cell
inhibitori
effect
increas
approxim
egcg
modifi
lyposom
tea
catechin
also
effect
herpesvirus
egcg
shown
block
ebv
lytic
cycl
inhibit
express
viral
gene
includ
rta
zta
ead
studi
indic
one
mechan
egcg
may
inhibit
ebv
lytic
cycl
involv
suppress
signal
pathway
involv
ebv
lytic
cycl
cascad
isaac
et
al
found
egcg
inactiv
hsv
virion
bind
envelop
glycoprotein
gb
gd
essenti
hsv
infect
egcg
digal
dimer
theasinensin
digal
inactiv
effect
monomer
egcg
dimer
stabl
vagin
ph
indic
potenti
antivir
agent
hsv
infect
inhibitori
effect
green
tea
extract
hbv
report
cell
egcg
inhibit
hbv
replic
impair
hbv
replic
intermedi
dna
synthesi
therebi
reduc
product
hbv
coval
close
circular
dna
contrast
huang
et
al
found
egcg
decreas
hbv
entri
immort
human
primari
hepatocyt
effect
hbv
genom
replic
furthermor
egcg
abl
enhanc
lysosom
acidif
unfavor
condit
hbv
replic
besid
virus
egcg
found
exert
antivir
activ
hcv
prevent
attach
viru
cell
surfac
suppress
rna
replic
step
recent
studi
also
show
inhibitori
activ
egcg
anoth
flaviviru
zika
viru
zikv
studi
foci
form
unit
reduct
assay
perform
evalu
antivir
activ
egcg
zikv
differ
stage
viru
replic
foci
observ
show
inhibit
cell
treat
egcg
viru
entri
similarli
egcg
abl
block
chikv
attach
target
cell
effect
stage
infect
naringenin
belong
flavanon
class
shown
reduc
replic
neurovirul
strain
sindbi
viru
vitro
also
reduc
sindbi
viru
semliki
forest
virusinduc
cytopath
effect
viru
yield
experi
interestingli
naringin
glycosid
form
naringenin
antisindbi
viru
activ
indic
rutinos
moieti
flavanon
block
antivir
effect
naringenin
also
abl
block
assembl
intracellular
hcv
particl
longterm
treatment
lead
log
reduct
hcv
alphaviru
chikv
effect
inhibit
infect
vero
cell
treat
naringenin
postentri
stage
studi
hesperetin
anoth
flavanon
found
richli
citru
fruit
found
exert
potent
antichikv
effect
viru
intracellular
replic
molecular
dock
molecular
dynam
studi
oo
et
al
also
reveal
strong
stabl
interact
hesperetin
chikv
nonstructur
protein
well
nonstructur
protein
suggest
protein
may
target
hesperetin
antichikv
activ
genistein
isoflavonoid
found
number
plant
includ
soybean
fava
bean
tyrosin
kinas
inhibitor
genistein
reduc
bovin
herpesviru
type
new
world
arenaviru
pichind
replic
prevent
phosphoryl
viral
protein
kinas
inhibitor
cocktail
contain
genistein
display
broadspectrum
antivir
activ
arenavirus
filovirus
genistein
shown
inhibit
hiv
infect
rest
cell
macrophag
interfer
hivmedi
actin
dynam
furthermor
may
act
hiv
ion
channel
sinc
abil
block
viral
vpu
protein
believ
form
cationperm
ion
channel
infect
cell
genistein
also
exert
antivir
effect
replic
avian
leucosi
viru
subgroup
j
inhibit
viru
transcript
antivir
activ
flavonoid
present
tabl
spite
wide
rang
biolog
health
benefit
flavonoid
possess
addit
high
avail
human
daili
diet
challeng
ahead
research
natur
compound
appli
therapeut
option
clinic
set
bioavail
defin
us
food
drug
administr
rate
extent
activ
ingredi
activ
moieti
absorb
drug
product
becom
avail
site
action
main
stumbl
block
advanc
potenti
use
flavonoid
medic
commun
intak
metabol
deriv
flavonoid
variou
food
sourc
lead
rel
larg
differ
final
amount
success
absorb
util
human
factor
molecular
size
glycosyl
esterif
lipophil
interact
enter
microorgan
pka
metabol
conjug
along
alimentari
tract
affect
absorpt
bioavail
flavonoid
human
henc
effort
enhanc
bioavail
flavonoid
upon
intak
human
vital
necessari
order
develop
natur
compound
potenti
antivir
drug
follow
exampl
effort
carri
tackl
issu
use
platform
success
futur
past
research
look
altern
method
improv
compound
solubl
switch
site
absorpt
gut
aim
enhanc
bioavail
structur
modif
result
chang
site
absorpt
larg
small
intestin
success
yield
higher
plasma
level
hesperetin
healthi
subject
wang
et
al
formul
way
increas
oral
bioavail
flavonol
extract
sea
buckthorn
form
phospholipid
complex
via
solvent
evapor
method
rel
parent
compound
oral
bioavail
test
flavonol
higher
phospholipid
complex
administ
rat
flavonoid
load
engin
nanoparticl
also
test
bioavail
follow
oral
consumpt
improv
stabil
catechin
egcg
chitosan
nanoparticl
shown
result
higher
rate
intestin
absorpt
poli
llactid
pla
nanoparticl
polymer
micel
contribut
sustain
releas
quercetin
poor
bioavail
undergo
substanti
firstpass
metabol
well
poorli
absorb
apigenin
selfmicroemulsifi
drug
deliveri
system
smdd
anoth
technolog
use
overcom
problem
low
bioavail
hydrophob
molecul
upon
enter
lumen
intestin
oilinwat
microemuls
contain
drug
form
microemuls
increas
intestin
absorpt
drug
compound
avoid
dissolut
process
puerarin
isoflavon
isol
root
pueraria
lobata
exhibit
higher
bioavail
prepar
use
smdd
howev
worth
note
bioavail
flavonoid
increas
via
differ
methodolog
vital
biolog
efficaci
affect
maintain
enhanc
instanc
phosphoryl
icariin
found
inhibit
duck
hepat
viru
effect
parent
compound
isorhamnetin
methyl
flavonol
deriv
structur
quercetin
dayem
et
al
investig
antivir
potenc
isorhamnetin
influenza
viru
discov
methyl
group
b
ring
enhanc
antivir
activ
compar
test
flavonoid
efficaci
isorhamnetin
influenza
viru
also
shown
vivo
ovo
model
test
improv
bioavail
definit
enhanc
efficaci
differ
biolog
effect
class
flavonoid
henc
addit
discov
hidden
potenti
flavonoid
scientist
also
aim
identifi
way
increas
amount
flavonoid
avail
health
benefit
human
be
natur
compound
center
attent
among
research
work
variou
field
includ
relat
antivir
drug
develop
due
high
avail
low
side
effect
phytochem
flavonoid
abundantli
found
daili
diet
fruit
veget
activ
studi
potenti
therapeut
option
virus
differ
taxa
past
decad
numer
posit
find
report
vitro
efficaci
flavonoid
less
promis
result
obtain
compound
vivo
studi
multipl
factor
contribut
scenario
vivo
studi
must
priorit
research
wellknown
flavonoid
possess
enorm
potenti
includ
daili
prescript
physician
treat
ill
rang
infecti
oncogen
inflammatori
chronic
degen
diseas
howev
time
research
worldwid
take
initi
make
compound
success
vitro
stage
research
also
anim
model
well
subsequ
clinic
studi
biochemistri
mechanist
studi
flavonoid
inhibitori
activ
improv
understand
natur
compound
work
hand
identifi
stumbl
block
hinder
improv
flavonoid
antivir
research
